Acute Heart Failure Study in Patients Admitted to Emergency Department for Dyspnea (PREDICA)

January 13, 2022 updated by: University Hospital, Toulouse

Predictive Criteria of Acute Heart Failure (AHF) in Patients Admitted to Emergency Department for Dyspnea.

No studies have analyzed the predictive value of different anamnestic and clinical signs for the diagnosis of acute heart failure (AHF) in patients admitted to emergency department. That's why the expert group of the AHF of South West of France mobilizes to conduct this study to evaluate the diagnostic predictive value of different anamnestic and clinical signs for the diagnosis of AHF to emergencies.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

There is no recommendation of the French Society of Emergency Medicine (SFMU) on the management of the acute heart failure in the emergency department.

The present study hypothesizes that identifying anamnestic and clinical criteria of AHF in patients admitted to emergency department for acute dyspnea would optimize the management of these patients upon arrival to the emergency department and to implement rapidly the appropriate therapeutic strategies.

All patients admitted for dyspnea will be enrolled by the emergency physicians (after verification of inclusion and exclusion criteria) in the 3 participating centers.

Then, all files will be analyzed retrospectively from information collected by a committee of experts cardiologists and emergency physicians of each center.

The primary objective is the evaluation of diagnostic predictive value of different anamnestic and clinical signs for the diagnosis of AHF in emergency department for the construction of a clinical prediction score of acute heart failure. The secondary objective is the description of the diagnostic and therapeutic management of patients admitted to the emergency for acute dyspnea.

Study Type

Observational

Enrollment (Actual)

342

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Bordeaux, France, 33000
        • University Hospital
      • Pau, France, 64000
        • Hospital
      • Toulouse, France, 31000
        • University Hospital toulouse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The population from which the cohort will be selected is patients admitted to hospital center emergency department of Toulouse, Bordeaux and Pau.

Description

Inclusion Criteria:

  • patients ≥ 18 years
  • Admitted to emergency department for acute dyspnea

Exclusion Criteria:

  • Traumatic dyspnea
  • shock / Systolic blood pressure <90 mmHg

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diagnosis of AHF after expertise
Time Frame: 12 months
The final diagnosis of AHF after expertise of patients records by a committee of experts cardiologists and emergency physicians.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic and therapeutic management of patients admitted to the emergency for acute dyspnea
Time Frame: Baseline
The secondary objective is the description of the diagnostic and therapeutic management of patients admitted to the emergency for acute dyspnea
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Toulouse

Investigators

  • Principal Investigator: CHARPENTIER Sandrine, MD PhD, University Hospital, Toulouse
  • Principal Investigator: RONCALLI Jérome, MD PhD, University Hospital, Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

July 7, 2016

First Submitted That Met QC Criteria

July 13, 2016

First Posted (Estimate)

July 18, 2016

Study Record Updates

Last Update Posted (Actual)

January 28, 2022

Last Update Submitted That Met QC Criteria

January 13, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RC/31/15/7672

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe